M. Robyn Andersen, PhD, MPH
Advertisement
Articles by M. Robyn Andersen, PhD, MPH
More than 26% of cancer patients see CAM providers, primarily for musculoskeletal problems; use does not vary by treatment phase, and associated expenditures are low.
Advertisement
Latest Updated Articles
- Complementary and Alternative Medicine in Cancer Care
September 14th 2008
Advertisement
Advertisement
Trending on AJMC
1
5 August FDA Approvals Marked by Novelty, Pushback
2
Newer Agents, New Advantages: Brexpiprazole, Cariprazine, and Lumateperone in MDD
3
Dosing, Tolerability, and Formulary Impact: Aripiprazole and Quetiapine XR in MDD
4
Cross-Trial Vitiligo Data: What Payers Can and Can't Compare
5